A Cancer Conundrum: Too Many Drug Trials, Too Few Patients By GINA KOLATA from NYT Health http://ift.tt/2fBCrz7 via IFTTT Tweet Postingan terkait: Top Executives of Insys, an Opioid Company, Found Guilty of RacketeeringTop Executives of Opioid Company Found Guilty of RacketeeringF.D.A. Won’t Ban Sales of Textured Breast Implants Linked to CancerTrump Administration Files Formal Request to Strike Down All of ObamacareMcKesson, Drug Distribution Giant, Settles Lawsuit Over Opioids in West Virginia
Belum ada tanggapan untuk "A Cancer Conundrum: Too Many Drug Trials, Too Few Patients"
Posting Komentar